Q2 2018 Earnings Highlight Strong Results

"Lilly delivered strong results once more in the second quarter in terms of operational performance, pipeline advancements and strategic objectives," said David A. Ricks, Lilly’s chairman and CEO. "The increase in our worldwide revenue was fueled by volume growth of our new medicines, while we also maintained a keen focus on containing costs and improving productivity. Our pipeline continued to demonstrate our commitment to scientific innovation, highlighted by forward progress for key molecules, several positive late-stage data readouts and the addition of promising new assets through business development."

For more information and the full readout of results, view the press release and visit our Investors site.

Q2 2018 Earnings Infographic

See the Announcement